--- title: "MYNZ.US (MYNZ.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/MYNZ.US/news.md" symbol: "MYNZ.US" name: "MYNZ.US" parent: "https://longbridge.com/en/quote/MYNZ.US.md" datetime: "2026-03-08T08:16:58.483Z" locales: - [en](https://longbridge.com/en/quote/MYNZ.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/MYNZ.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/MYNZ.US/news.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MYNZ.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MYNZ.US/news.md) # MYNZ.US (MYNZ.US) — Related News ### [Zealand Pharma's stock price plummeted 35% due to disappointing drug trial results](https://longbridge.com/en/news/278139134.md) *2026-03-06T16:33:53.000Z* > Shares of Zealand Pharma plummeted 35% due to disappointing results from its latest drug trial. CEO Adam Steensberg stat ### [](https://longbridge.com/en/news/278051748.md) *2026-03-06T08:08:47.000Z* > ZEALAND PHARMA's stock price plummeted to a record low, falling by 32% due to data related to obesity drugs ### [Pre-market hot trades in US stocks: Mainz Biomed NV pre-market down 9.68%; Neo-Concept pre-market down 8.47%](https://longbridge.com/en/news/276213924.md) *2026-02-18T09:52:33.000Z* > Mainz Biomed NV pre-market down 9.68%; Neo-Concept pre-market down 8.47%; Kebaike Technology pre-market up 61.11%; Auddi ### [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://longbridge.com/en/news/276150613.md) *2026-02-17T17:05:59.000Z* > In Tuesday's intraday session, Polaryx Therapeutics (PLYX) saw a significant gain of 80.9%, reaching $4.36, with a marke ### [](https://longbridge.com/en/news/276151368.md) *2026-02-17T17:05:54.000Z* > Mainz Biomed shares are trading lower. The company announced a $6 million private placement and strategic updates. ### [](https://longbridge.com/en/news/275867131.md) *2026-02-13T08:06:01.000Z* > Zealand's stock price fell by 3.7%, reaching its lowest level since August 2025 ### [Mainz Biomed Completes ATM Offering](https://longbridge.com/en/news/275517406.md) *2026-02-10T22:03:00.000Z* > On February 10, 2026, Mainz Biomed announced the completion of its ATM offering with Maxim Group LLC. Key Highlights: So ### [](https://longbridge.com/en/news/274955020.md) *2026-02-05T10:28:37.000Z* > Xilan Pharmaceutical Company's stock price fell 5% in early trading ### [Mainz Biomed NV Files Initial Statement of Beneficial Ownership for CFO William Caragol](https://longbridge.com/en/news/273746660.md) *2026-01-26T21:09:06.000Z* > Mainz Biomed NV has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission,